Abstract: A system includes a catheter, a pulse generator and a controller. The catheter is configured for insertion into a body of a patient, and includes at least a first electrode, a second electrode and a third electrode, which are disposed at a distal end of the catheter and are configured to contact tissue within the body. The pulse generator is configured to apply one or more bipolar ablation pulses between the first and second electrodes, for ablating the tissue in contact with the first and second electrodes. The controller is configured to: (i) control the pulse generator to apply the one or more bipolar ablation pulses between the first and second electrodes, (ii) receive a signal indicative of a voltage, measured between the third electrode and a reference during application of the ablation pulses, and (iii) issue a notification in response to detecting that the voltage violates a predefined criterion.

Abstract: A switching assembly for transferring trains of pulses, including a first terminal and a second terminal. A first plurality of first relays is connected in parallel, and have first contacts connected to the first assembly terminal, and second contacts. A first capacitor is connected in parallel with the first relays. A second plurality of second relays is connected in parallel, and have third contacts, and fourth contacts connected to the second assembly terminal. A second capacitor is connected in parallel with the second relays. A connection connects the second contacts to the third contacts. The pulses have amplitudes of at least 2 kilovolts. On activation of the first and second relays the first and second contacts connect and the third and fourth contacts connect, so that the first and second assembly terminals connect. On deactivation of the first and second relays the first and second assembly terminals disconnect.

Abstract: A tissue puncture system includes a guidewire and a handle. The guidewire is configured to be inserted into an organ of a patient and to puncture tissue of the organ by conducting an electrical signal from a power source and applying to the tissue electrical current induced between a distal surface of the guidewire and the tissue. The handle is configured to: (i) electrically connect between the power source and a proximal surface of the guidewire, and (ii) move the distal surface to the tissue.

Abstract: A medical apparatus includes a probe, which includes an insertion tube configured for insertion into a body cavity of a patient, and a distal assembly, which is connected distally to the insertion tube and includes a plurality of electrodes, which are configured to contact tissue within the body cavity. The apparatus further includes an electrical signal generator, which is configured to apply electrical pulses to a group of two or more of the electrodes with an amplitude sufficient to irreversibly electroporate the tissue contacted by the electrodes in the group, and a controller, which is coupled to measure a change in an electrical impedance between an electrode in the group and a further electrode as a result of application of the electrical pulses and to output a measure of ablation of the tissue responsively to the measured change in the electrical impedance.

Abstract: An irreversible electroporation (IRE) method includes receiving a total number of IRE pulses to be applied by one or more electrodes of a catheter placed in proximity to a tissue in an organ. An IRE protocol is defined by defining a partitioning of the total number of the IRE pulses into multiple pulse trains separated by pauses, the partitioning defined so as to reduce a total duration of the IRE protocol while meeting a safety criterion. The IRE protocol is applied to the tissue using the electrodes.

Abstract: A medical apparatus includes a probe configured for insertion into a body of a patient and including three or more electrodes arrayed along a distal portion of the probe and configured to contact tissue within the body. An electrical signal generator is configured to apply between a selected pair of the electrodes signals having an amplitude sufficient to ablate the tissue contacted by the pair of the electrodes. A controller is configured to measure an electrical current flowing through at least one of the electrodes not included in the selected pair while applying the signals, and to issue a notification indicating that the tissue was inadequately ablated if the measured electrical current exceeds a preset threshold.

Abstract: An irreversible electroporation (IRE) system includes an IRE ablation power source configured to generate bipolar IRE pulses, a switching assembly, and a processor. The switching assembly is configured to short-circuit a first group and a second group of electrodes of a catheter, the groups of electrodes configured to be placed in contact with tissue of organ, so as to create respective combined electrodes of a first size and a second size smaller than the first size, and to connect the IRE ablation power source to the groups of electrodes. The processor is configured to receive target tissue depth of ablation, select the groups of the electrodes, to control the switching assembly to create the combined electrodes and to ablate the tissue by controlling the switching assembly to apply the bipolar IRE pulses to the groups of electrodes to ablate tissue location in contact with a combined electrode to target depth.

Abstract: A system includes a catheter, a pulse generator and a controller. The catheter is configured for insertion into a body of a patient, and includes at least a first electrode, a second electrode and a third electrode, which are disposed at a distal end of the catheter and are configured to contact tissue within the body. The pulse generator is configured to apply one or more bipolar ablation pulses between the first and second electrodes, for ablating the tissue in contact with the first and second electrodes. The controller is configured to: (i) control the pulse generator to apply the one or more bipolar ablation pulses between the first and second electrodes, (ii) receive a signal indicative of a voltage, measured between the third electrode and a reference during application of the ablation pulses, and (iii) issue a notification in response to detecting that the voltage violates a predefined criterion.

Abstract: A method includes inserting into an organ a catheter having multiple electrodes, and placing the electrodes in contact with tissue for ablation. A selection from among the electrodes is received, including (i) first and second electrodes defining a first section of the catheter having a plurality of the electrodes, and (ii) third and fourth electrodes defining a second section of the catheter having at least two of the electrodes. Identifying whether the first and second sections jointly form a single contiguous ablation line or two disjoint ablation lines. A first set of ablation pulses is applied to the electrodes of the first and second sections, in case the first and second sections form the single contiguous ablation line, or a second different set of ablation pulses is applied to the electrodes of the first and second sections, in case the first and second sections form the two disjoint ablation lines.

Abstract: A medical apparatus includes a probe configured for insertion into a body of a patient and including three or more electrodes arrayed along a distal portion of the probe and configured to contact tissue within the body. An electrical signal generator is configured to apply between a selected pair of the electrodes signals having an amplitude sufficient to ablate the tissue contacted by the pair of the electrodes. A controller is configured to measure an electrical current flowing through at least one of the electrodes not included in the selected pair while applying the signals, and to issue a notification indicating that the tissue was inadequately ablated if the measured electrical current exceeds a preset threshold.

Abstract: A medical apparatus includes a probe, including an insertion tube configured for insertion into a body cavity of a patient and a basket assembly, which has a proximal end that is connected distally to the insertion tube and includes a plurality of resilient spines, which are configured to bow radially outward around a longitudinal axis of the basket assembly and are conjoined at a distal end of the basket assembly. A plurality of electrodes are configured to contact tissue in the body cavity and include radial electrodes disposed on the spines and an axial electrode disposed on the longitudinal axis of the basket assembly. An electrical signal generator is configured to apply to the electrodes, including the axial electrode, pulses having an amplitude sufficient to cause irreversible electroporation (IRE) in the tissue contacted by the electrodes.

Abstract: The present invention, in some embodiments thereof, relates to a devices and methods for intravascular denervation and assessment thereof and, more particularly, but not exclusively, to devices and methods for renal denervation. Some embodiments of the invention relate to an intravascular catheter configured for ultrasonic ablation of the tissue, comprising a plurality of piezoelectric transceivers. In some embodiments, an intravascular distancing device is provided, the device adapted for obtaining at least a minimal distance between an ultrasound emitting element and a tissue, such as the blood vessel wall. Some embodiments of the invention relate to assessment of renal sympathetic denervation (RSD) treatment effectiveness. Some embodiments of the invention relate to processing echo of signals, such as processing of signals to characterize physical and/or mechanical properties of the blood vessel.

Abstract: The present invention, in some embodiments thereof, relates to a devices and methods for intravascular denervation and assessment thereof and, more particularly, but not exclusively, to devices and methods for renal denervation. Some embodiments of the invention relate to an intravascular catheter configured for ultrasonic ablation of the tissue, comprising a plurality of piezoelectric transceivers. In some embodiments, an intravascular distancing device is provided, the device adapted for obtaining at least a minimal distance between an ultrasound emitting element and a tissue, such as the blood vessel wall. Some embodiments of the invention relate to assessment of renal sympathetic denervation (RSD) treatment effectiveness. Some embodiments of the invention relate to processing echo of signals, such as processing of signals to characterize physical and/or mechanical properties of the blood vessel.

Abstract: Some embodiments of the invention relate to a method of treating pulmonary hypertension comprising: introducing a catheter device comprising one or more energy emitting transceivers into the pulmonary artery lumen; positioning the one or more transceivers within the left, right and/or main pulmonary artery at a location which is in between the first bifurcation of the left pulmonary artery and the first bifurcation of the right pulmonary artery; and thermally damaging nerve tissue by emitting energy having parameters selected to damage nerves only within a distance window of between 0.2 mm and 20 mm from the intimal aspect of the pulmonary artery wall when the one or more transceivers are positioned at the selected location.

Abstract: The present invention in some embodiments thereof relates to a method for selectively modifying nerve activity without causing substantial damage to non-targeted tissue, comprising introducing a catheter device comprising one or more ultrasonic transceivers to the pulmonary artery lumen, receiving, using the one or more ultrasonic transceivers, echo signals reflected from the non-targeted tissue following emission of ultrasound energy by the one or more transceivers, analyzing the received echo signals to identify at least one of a type and location of the non-targeted tissue relative to the one or more transceivers, and emitting ultrasound energy from the one or more ultrasonic transceivers in accordance with the analysis, to modify nerve activity without substantially damaging the identified non-targeted tissue.

Abstract: The present invention in some embodiments thereof relates to a method for selectively modifying nerve activity without causing substantial damage to non-targeted tissue, comprising introducing a catheter device comprising one or more ultrasonic transceivers to the pulmonary artery lumen, receiving, using the one or more ultrasonic transceivers, echo signals reflected from the non-targeted tissue following emission of ultrasound energy by the one or more transceivers, analyzing the received echo signals to identify at least one of a type and location of the non-targeted tissue relative to the one or more transceivers, and emitting ultrasound energy from the one or more ultrasonic transceivers in accordance with the analysis, to modify nerve activity without substantially damaging the identified non-targeted tissue.

Abstract: The present invention, in some embodiments thereof, relates to a devices and methods for intravascular denervation and assessment thereof and, more particularly, but not exclusively, to devices and methods for renal denervation. Some embodiments of the invention relate to an intravascular catheter configured for ultrasonic ablation of the tissue, comprising a plurality of piezoelectric transceivers. In some embodiments, an intravascular distancing device is provided, the device adapted for obtaining at least a minimal distance between an ultrasound emitting element and a tissue, such as the blood vessel wall. Some embodiments of the invention relate to assessment of renal sympathetic denervation (RSD) treatment effectiveness. Some embodiments of the invention relate to processing echo of signals, such as processing of signals to characterize physical and/or mechanical properties of the blood vessel.